Analysis of Gut Microbiota in Coronary Artery Disease Patients: a Possible Link between Gut Microbiota and Coronary Artery Disease

Takuo Emoto, Tomoya Yamashita, Naoto Sasaki, +9

Journal of Atherosclerosis and Thrombosis

Characterization of gut microbiota profiles in coronary artery disease patients using data mining analysis of terminal restriction fragment length polymorphism: gut microbiota could be a diagnostic marker of coronary artery disease

Takuo Emoto, Tomoya Yamashita, Toshio Kobayashi, +10

Heart and Vessels

ProbioticDysbiosisMolecular EpidemiologyGut MicrobiologyGut Microbiota Profiles +9

Commensal bacteria at the crossroad between cholesterol homeostasis and chronic inflammation in atherosclerosis

Kazuyuki Kasahara, Takeshi Tanoue, Tomoya Yamashita, +10

Journal of Lipid Research

Overexpression of Cytotoxic T-Lymphocyte–Associated Antigen-4 Prevents Atherosclerosis in Mice

Takuya Matsumoto, Naoto Sasaki, Tomoya Yamashita, +9

Arteriosclerosis Thrombosis and Vascular Biology

Foxp3 ⁺ Regulatory T Cells Play a Protective Role in Angiotensin II–Induced Aortic Aneurysm Formation in Mice

Keiko Yodoi, Tomoya Yamashita, Naoto Sasaki, +8

Hypertension

Vascular DiseaseT-regulatory CellImmune RegulationImmunologyTreg Expansion +18

Regression of atherosclerosis with anti-CD3 antibody via augmenting a regulatory T-cell response in mice

Tomoyuki Kita, Tomoya Yamashita, Naoto Sasaki, +6

Cardiovascular Research

Torsades de Pointes with QT prolongation related to donepezil use

Tomofumi Takaya, Masashi Okamoto, Keiko Yodoi, +8

Journal of Cardiology

MedicinePhysiologyQt Prolongation

Rates and Extents of Antifungal Activities of Amphotericin B, Flucytosine, Fluconazole, and Voriconazole against <i>Candida lusitaniae</i> Determined by Microdilution, Etest, and Time-Kill Methods

Erika J. Ernst, Keiko Yodoi, Ellen E. Roling, +1

Antimicrobial Agents and Chemotherapy

Clinical MycologyAntimicrobial ChemotherapyDrug ResistanceAmphotericin BAntimicrobial Therapy +17

Regulatory/Effector T-Cell Ratio Is Reduced in Coronary Artery Disease

Takuo Emoto, Naoto Sasaki, Tomoya Yamashita, +6

Circulation Journal

CD3 Antibody and IL‐2 Complex Combination Therapy Inhibits Atherosclerosis by Augmenting a Regulatory Immune Response

Kazuyuki Kasahara, Naoto Sasaki, Tomoya Yamashita, +5

Journal of the American Heart Association